GSK-HZC113782

Study Sponsor: GSK

Study Title

A Clinical Outcomes Study to compare the effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg with placebo on Survival in Subjects with moderate Chronic Obstructive Pulmonary Disease (COPD) and a history of or at increased risk for cardiovascular disease

Medicine or Vaccine (generic name)

fluticasone furoate/vilanterol

Sponsor Identification Number

HZC113782

Trial Registry Identification Number(#'s)

NCT01313676 2010-021638-72

Medical Condition

Pulmonary Disease, Chronic Obstructive

Phase

Phase 3

Link to GSK Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=113782

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT01313676

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=2010-021638-72

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

There is a Publication Steering Committee for this study.

Date Added to this Site

June 2016